Precision for Medicine (BEL)
- 0764.663.668
- BE0764663668
- Boulevard Saint-Lazare 4/10, 1210 Saint-Josse-ten-Noode
- See the 31 companies at this address
- 4 March 2021
Profile
Official information from the CBE (FPS Economy).
Precision for Medicine (BEL) is a Belgian company (Société à responsabilité limitée) whose registered office is established at 1210 Saint-Josse-ten-Noode. Its main activity falls under “Recherche-développement en autres sciences physiques et naturelles” (NACE 72109).
- Legal form
- Société à responsabilité limitée
- Legal situation
- Situation normale
- Date of incorporation
- 4 March 2021
- Main activity (NACE)
- 72109Recherche-développement en autres sciences physiques et naturelles
An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more
Your risk analysis on this company
AML Company ran Precision for Medicine (BEL) through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Trading, no proceedings· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
1 active establishment unit declared with the CBE.
Finances & financial health
Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).
Equity & result
| Financial year | Equity | Result | Turnover / gross margin | Headcount (FTE) |
|---|---|---|---|---|
| 2025 | -€712,904 | €40,673 | €754,459gross margin | – |
| 2022 | -€304,946 | €53,620 | €762,398gross margin | – |
| 2021 | -€358,566 | -€368,566 | €60,557gross margin | – |
Financial ratios
Solvency, liquidity and profitability, computed year by year from the filed annual accounts.
Equity / balance sheet total
Current assets / debts due within one year
This year's filing does not carry the item the calculation needs.
Result for the year / turnover
This year's filing does not carry the item the calculation needs.
Operating result / turnover
This year's filing does not carry the item the calculation needs.
Debts due after one year / balance sheet total
The filed denominator is zero or negative: the ratio would carry no meaning.
Result for the year / equity
Balance sheet structure
| Ratio | 2025 | 2022 | 2021 | Trend |
|---|---|---|---|---|
| Solvency | -236,1% 203,9% | -32,2% 158,3% | -190,5% | |
| Liquidity | 0,29 x 0,46 | 0,75 x 0,41 | 0,34 x | |
| Net margin | - | - | - | - |
| Operating margin | - | - | - | - |
| Long-term debt | - | - | - | - |
| Return on equity | - | - | - | - |
Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.
Filing history (3)▾
Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.
The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- DEMISSIONS, NOMINATIONS15 May 2026
- DEMISSIONS, NOMINATIONS12 March 2026
- DEMISSIONS, NOMINATIONS28 February 2025
- SIEGE SOCIAL28 January 2025
- DEMISSIONS, NOMINATIONS30 April 2024
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
What the Precision for Medicine (BEL) record does not say
Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.
Is Precision for Medicine (BEL) subject to anti-money-laundering obligations in Belgium?
Did Precision for Medicine (BEL) file its annual accounts on time?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2026
- 1 July 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m87-fFiled accounts2026-00250895
- 2025
- 2024
- 2023
- 18 August 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m81-fFiled accounts2023-00343381
- 2022
- 31 August 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m81-fFiled accounts2022-20418731
- 2021
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
COST Association
Resource Matters
Antimicrobial Consumption and Resistance in Animals
European Alliance on Agricultural Knowledge for Development
Novocure Belgium
Pliant Therapeutics Belgium
RECHERCHE ET SANTE
BEX
Consultants for Research in Imaging and Spectroscopy - Innovative Solutions
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.